Development and validation of HPLC-FLD method for simultaneous determination of ternary therapy used for COVID-19 in plasma samples

Eman A. Madbouly, Abdalla A. El-Shanawani, Sobhy M. El-Adl, Ahmed S. Abdelkhalek · 2026

Read Development and validation of HPLC-FLD method for simultaneous determination of ternary therapy used for COVID-19 in plasma samples by Eman A. Madbouly, Abdalla A. El-Shanawani, Sobhy M. El-Adl, Ahmed S. Abdelkhalek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13272654.txt.

Description

Eman Madbouly leads a 2026 study presenting a new lab method to measure three COVID-19 drugs at once in human blood plasma. The drugs are remdesivir, levodropropizine, and moxifloxacin, used together as a triple therapy. The method uses liquid chromatography with fluorescence detection and a soap-like mobile phase.

The test was linear over set ranges for all three drugs and showed high accuracy and precision, using losartan as an internal standard. The authors rate the method as green, meaning low harm to the environment, on three scoring tools. They propose it for routine quality checks and for studies of how the body handles these drugs.

Catalog record

CREATOREman A. Madbouly, Abdalla A. El-Shanawani, Sobhy M. El-Adl, Ahmed S. Abdelkhalek
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63548
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13272654

Browse the full library · About the Tower of Babel